Childhood-onset striatonigral neurodegeneration robs children of the ability to walk and talk by age five. Researchers at ...

A cholesterol receptor protein called LDLR appears to be a key driver of neurotoxicity in sporadic ALS, per new research ...

The Australian News World-first human clinical trial to cure paralysis Professor James St John holding a Cervical spine 3D ...

Preclinical data with the investigational gene therapy INS1202 show improvements in survival and motor performance in ALS.

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

Amgen’s Uplizna (inebilizumab-cdon) has shown sustained efficacy in a group of gMG patients after 52 weeks in a Phase III ...

Spinal cord injury (SCI)—a condition that leads to partial ... The researchers used a non-human primate model to investigate the effects of edonerpic maleate on motor recovery following a partial ...

Spinal cord injury (SCI)—a condition that leads to partial or complete paralysis—has a profound impact on millions of individuals globally. Despite recent advances in SCI treatment, restoring lost ...

The pressure in the spinal canal and brain can then be measured. A small amount of CSF is removed and sent for testing to find out if there is high protein, an infection, or other problems.

Spinal stenosis is caused by a narrowing of your spinal canal. This narrowing can irritate the nerves that travel down your legs. Symptoms such as lower back pain, radiating pain to the lower ...

This keeps the ligament from affecting the nerve root and frees up space in the spinal canal. You don’t have to be asleep for PILD, so it may be an option for people who can’t have surgery ...